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Abstract 
Infection with Mycobacterium wolinskyi, if not detected, may cause severe skin and soft tissue 
infection with prolonged healing process and is therefore associated with high morbidity. 
Only about 20 cases of M. wolinskyi infections in humans have been described in the litera-
ture until now, none of them in Switzerland. We report a case of an infection in a 72-year-old 
male patient with recurrent subcutaneous abdominal wall abscesses and ulcer formation 
after insulin injection in the underbelly. A culture of skin biopsy tissue showed rapid growth 
of non-tuberculous mycobacteria (NTM), which were identified by 16S rRNA gene sequenc-
ing as M. wolinskyi. Surgical excision and primary closure of all abdominal ulcers in combina-
tion with antibiotic therapy, based on the antimicrobiotic susceptibility test results, were per-
formed and resulted in complete resolution of the clinical symptoms and no recurrence of 
infection at a 6-month follow-up. The present case emphasizes the importance of accurate 
diagnosis and treatment of chronic infection with ulcer formation. In such cases, it is crucial 
to consider the presence of NTM, such as M. wolinskyi, in order to obtain rapid diagnosis, 
specific treatment and improved patient care. © 2016 The Author(s) 
 Published by S. Karger AG, Basel 
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Case Report 
A 72-year-old male patient with recurrent subcutaneous abdominal wall abscesses was 
referred to our dermatological inpatient unit at the University Hospital in Zurich, Switzer-
land. The abdominal skin problems had begun one and a half years before, after subcutane-
ous insulin injections in the underbelly region had been initiated. Within few days, the pa-
tient noticed a development of a small red indurated but indolent nodule in the right umbili-
cal region. The patient’s medical history included insulin-dependent diabetes mellitus type 2, 
atrial fibrillation with oral anticoagulation and a previous percutaneous coronary interven-
tion due to a myocardial infarction. Five months later, local subcutaneous abscesses devel-
oped in the central abdominal wall region. The patient was referred to a nearby hospital for 
surgical wound debridement and received postoperative antibiotic treatment with oral 
amoxicillin and clavulanic acid. In the following months, there were several recurrences of 
abdominal wall abscesses turning into ulcers followed by repeated subsequent surgical deb-
ridements, excisions of abdominal wall fistulas, negative pressure wound therapies, as well 
as antibiotic therapies (amoxicillin and clavulanic acid).  
As the abscesses with ulcer formation did not improve in the long term, the suspicion of 
pyoderma gangrenosum arose and the patient was referred to our clinic for further derma-
tological investigations. At hospital admission, the patient was in a good clinical condition, 
without fever or infection signs. Clinical examination revealed three 2- to 5-cm-large oval 
ulcers with granulation tissue on the lower right central abdominal area, with slightly ery-
thematous but not undermined boarders (fig. 1a). Laboratory findings did not indicate a 
systemic infection with CRP 7 mg/l (range <5 mg/l), leukocytes 9 G/l (range 3.0–9.6 G/l). 
The differential diagnosis encompassed ulcers of either infectious, vasculitic or exogenous 
origin, open abdominal wall fistulas with ulcer formation as well as pyoderma gangrenosum.  
Bacterial swabs from the ulcers showed only the presence of the commensal skin flora. 
Pathergy phenomenon could not be detected clinically. The patient had no personality 
changes that would imply an obsessive-compulsive disorder resulting in self-mutilation. 
Serological vasculitis screen with antinuclear antibodies, ANCA, rheumatoid factor, comple-
ment C3/4 fraction, and hepatitis B and C serology was negative. Imaging studies of the ab-
domen with contrast-enhanced computed tomography (CT) and magnetic resonance imag-
ing (MRI) illustrated an abdominal subcutaneous fluid collection but no abdominal fistulas. A 
deep skin biopsy of the ulcers was performed and tissue culture started (for bacteria, fungi 
and mycobacteria). Histology revealed mixed inflammatory cellular infiltrates of neutrophils 
and histiocytes with granuloma and abscess formation in the dermis. No pathogen could be 
verified in different stainings (PAS, Grocott, Ziehl-Neelsen) (fig. 2). After 6 days of cultiva-
tion, skin biopsy tissue culture showed rapid growth of non-tuberculous mycobacteria 
(NTM), which were identified by 16S rRNA gene sequencing as Mycobacterium wolinskyi. 
The patient underwent surgical excision and primary closure of all abdominal ulcers with 
material being sent for further tissue culturing. The subsequent mycobacterial culture also 
yielded rapidly growing M. wolinskyi. Based on the antibiotic susceptibility test results (table 
1), the patient was treated with intravenous amikacin (500 mg per day) for 1 month in com-
bination with oral moxifloxacin (400 mg per day) and minocycline (100 mg twice a day) 
therapy for a total of 6 months. The patient responded well to this combination therapy with 
complete resolution of the clinical symptoms and no recurrence of infection at a 6-month 
follow-up (fig. 1b). 
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Discussion 
M. wolinskyi belongs to NTM, which comprise over 140 different species. M. wolinskyi is 
ubiquitously distributed in soil and water. In the Runyon classification system, M. wolinskyi 
is a type IV mycobacteria and is also called rapidly growing mycobacteria (RGM), meaning 
that it has the ability to grow within 7 days in culture media [1, 2]. M. wolinskyi was first 
identified by Brown et al. [3] in 1999 using 16S rRNA sequencing. Among many species of 
RGM, M. wolinskyi belongs to the M. smegmatis group, which includes M. smegmatis, M. wolin-
skyi and M. goodii. Mycobacteria of the M. smegmatis group are predominantly associated 
with skin and soft tissue infections [1, 2]. 
Only about 20 cases of M. wolinskyi infections in humans have been described in the lit-
erature until now. These were mainly skin and soft tissue infections that arose following 
surgery (hip prosthesis implantation, peritoneal dialysis, organ transplantation, heart sur-
gery, breast mammoplasty) and cosmetic procedures (filler injection and laser lipolysis) [1, 
4, 5]. Typically, skin infection with M. wolinskyi became apparent months after surgery, often 
causing extensive pus production and in some cases deeper tissue destruction with involve-
ment of adjacent bone.  
Conventional histopathological methods, such as Ziehl-Neelson staining are not always 
able to detect this mycobacterium and are therefore not specific for the diagnosis of M. 
wolinskyi. The diagnosis of M. wolinskyi requires culturing of a tissue sample in an appropri-
ate culture medium. Molecular detection and specification is performed using 16S rRNA 
sequencing [6, 7]. In our case, after culture results indicated the presence of acid fast bacilli, 
a commercial semiautomatic multiplex PCR assay (COBAS® TaqMan® MTB assay) combined 
with an in-house validated PCR assay to detect all Mycobacterium spp. [8] was performed in 
order to exclude M. tuberculosis complex. The results of the multiplex PCR indicated the 
presence of an NTM, which was further confirmed by 16S rRNA sequencing. The isolate was 
identified as M. wolinskyi, featuring a sequence identity of 100%.  
Due to variability in antimicrobial susceptibility, there is no standardized antimicrobial 
regime or duration of therapy for M. wolinskyi. Minimal inhibitory concentration testing for 
susceptibility in culture medium enables a choice of the most suited individualized therapy 
[1, 9]. A combination therapy with at least 2 antimicrobial agents is preferred [9]. M. wolin-
skyi are typically susceptible to quinolones, doxycycline, linezolids and sulfamethoxazole, 
but resistant to tobramycin, imipenem and clarithromycin [10]. Surgical debridement com-
bined with antimicrobial therapy contributes in general to the resolution of infection caused 
by M. wolinskyi [1].  
Our case is the first report of M. wolinskyi infection described in Switzerland. The exact 
route of infection in this case remains unclear. An infection at the moment of surgery is un-
likely, because the symptoms begun months before any surgical procedure was performed. 
There were also no known outbreaks during the time in the hospital, where the surgical 
revisions have been performed initially. It is more likely that the infection was associated 
with the insulin injections in the underbelly, with inoculation of these ubiquitously present 
mycobacteria in the soft tissue. Moreover, the diabetic background and associated immune 
suppression could have favored the propagation of these mycobacteria and the development 
of the clinically overt infection. However, past reports showed equal susceptibility to M. 
wolinskyi infection in immunosuppressed and immunocompetent patients [1]. 
The present case shows the difficulties and emphasizes the importance of accurate di-
agnosis and treatment in a situation with non-healing ulcers. Infection with M. wolinskyi, if 
not detected, causes severe skin and soft tissue infection with prolonged healing process and 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
14
4.
20
0.
17
.4
2 
- 6
/6
/2
01
6 
4:
52
:2
4 
PM
 Case Rep Dermatol 
DOI: 10.1159/000446470 © 2016 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/cde 
Bossart et al.: Ulcers as a Sign of Skin Infection with Mycobacterium wolinskyi: Report of a 
Case and Review of the Literature 
 
 
 
 
154 
is as such associated with high morbidity. Therefore, in case of chronic infection with ulcer 
formation, it is crucial to consider the presence of NTM, such as M. wolinskyi, in order to ob-
tain rapid diagnosis, specific treatment and lastly improved patient care. 
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Fig. 1. a The patient’s clinical appearance at hospital admission, showing multiple oval ulcers on the ab-
dominal wall. b The patient’s clinical appearance at the 6-month follow-up. 
 
 
 
Fig. 2. Histology of abdominal wall biopsy. Left panel (×5 original magnification) shows substantial dermal 
inflammation, which on the right panel (×40 original magnification) reveals mixed inflammatory cellular 
infiltrates of neutrophils and histiocytes with granuloma and abscess formation. Hematoxylin and eosin 
stain. 
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Table 1. Minimal inhibitory concentration breakpoints 
    
    
Mycobacterium 
wolinskyi 
Breakpoints  MIC result, 
mg/l   S≤ R>  
     
     
Amikacin 16 064    
Tobramycin 02 008  0064 
Clarithromycin 02 008  >256 
Linezolid 08 032  0004 
Doxycycline 01 008  0032 
Tigecycline na na  0.0.0.5–1 
Minocycline 01 008  00..1 
Ciprofloxacin 01 004  0.0.0.5–1 
Levofloxacin 01 004  0.0.0.5 
Moxifloxacin 01 004  0.0.0.5–1 
Ethambutol na na  0008 
Imipenem 04 032  0016–32 
Meropenem 04 032  0016–32 
Cefoxitin 16 128  0128 
Clofazimine na na  .0.<0.5 
   
   
MIC = Minimal inhibitory concentration; S = sensible; 
R = resistant; na = not available. 
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